What Happened?
Shares of genomics company Illumina (NASDAQ: ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to its board and a price target increase from Barclays.
Illumina appointed Daniel M. Skovronsky, the Chief Scientific and Product Officer of Eli Lilly, to its board of directors. The move was viewed positively, as his expertise is expected to help the company's innovation and business development efforts. Separately, Barclays analyst Luke Sergott raised the firm's price target on Illumina to $145 from $122. While the analyst kept an Underweight rating on the shares, the note mentioned that life science and diagnostic tools are “gaining favor among healthcare subsectors,” and the firm expects in-line to modest beats in quarterly results for the group.
Is now the time to buy Illumina? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Illumina’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 8 months ago when the stock gained 22.4% on the news that it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year guidance.
Illumina announced non-GAAP earnings of $1.34 per share, which was well above analyst estimates of $1.17. While revenue for the quarter remained flat year on year at $1.08 billion, it also surpassed expectations. The positive market reaction was largely fueled by the company's improved forecast. Management raised its full-year adjusted earnings per share guidance to a midpoint of $4.70, a 4.4% increase from its previous outlook.
Illumina is up 30.8% since the beginning of the year, and at $175.70 per share, it has set a new 52-week high. Despite the year-to-date gain, investors who bought $1,000 worth of Illumina’s shares 5 years ago would now be looking at only $375.38.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
